Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam. - Wikidata - wikimedia - TriplyDB

Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam.

Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam.

http://www.wikidata.org/entity/Q40546181

about

Piperacillin/tazobactam-induced paresthesiae.Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability.High incidence of neutropenia in patients with prolonged ceftaroline exposure.Deferiprone-induced agranulocytosis: 20 years of clinical observations.High incidence of discontinuations due to adverse events in patients treated with ceftaroline.Thiopental-induced neutropenia in two patients with severe head trauma.Piperacillin/tazobactam Induced Myelosuppression.Flucloxacillin associated neutropenia in children treated for bone and joint infections.Cephalosporin-induced leukopenia following rechallenge with cefoxitin.HIV-related neutropaenia exacerbated by efavirenz.Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections.

P2860

Q33370885-87EA8CD8-A467-49B9-9940-4516555801C5 Q33402065-65182A4B-F3F2-4276-9179-C96CA66F0A75 Q33408895-0BF6989E-FEFD-4D1D-A599-35D72E545317 Q35206338-B47D8F4E-4D3A-4FC1-AF09-165C8C40C98D Q36977384-12CAD4C6-F0E5-46F3-A903-826ED337102A Q37456259-847CD51C-F443-41F1-A699-A55F06604153 Q38210123-4E9F4823-87A5-4234-9D54-773AED2AB07D Q40457228-945ACB15-C48A-4A1D-9F6E-96303DCCBE9F Q42260223-4C374B76-7411-414E-A17E-92ACB03ACEF2 Q44269753-C4DAD27E-ED8D-40FC-A40E-AB027F92C917 Q46468314-C106E214-1EE1-4795-9274-70E64DA4F2FB Q46899243-95075ACE-B706-4651-9719-F5579FAEFE2E Q47230552-3E9CA375-2B46-45AD-A3F1-50D493643D8D

P2860

Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam.

http://www.wikidata.org/entity/Q40546181

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Incidence of neutropenia durin ...... with piperacillin-tazobactam.

@en

type

label

Incidence of neutropenia durin ...... with piperacillin-tazobactam.

@en

prefLabel

Incidence of neutropenia durin ...... with piperacillin-tazobactam.

@en

P1433

Q40546181-543D148C-4E12-4B00-855F-E15FA36A69BD

P1476

Q40546181-46B2792F-83DC-4E50-BA1F-13F3D97AC3CD

P2093

Q40546181-0271CD33-8B1C-4BFB-A561-23779CD72B05

Q40546181-13943B67-D10A-4088-96FE-E0ED7BB7369B

Q40546181-78A39750-B44E-4FDC-B5EF-070AA5C1F698

Q40546181-8991C79F-1A27-4C22-8F19-251621F2CB99

Q40546181-DE563AFD-4D79-4B7B-90F6-E231BE0445F9

Q40546181-E08409A7-C615-4D8E-A790-F9993CCA98EB

P2860

Q40546181-0CD07F98-4D57-425F-B662-2F6F55FE1BFD

Q40546181-16450171-82CF-4CB2-B397-8688E036842D

Q40546181-278099DD-C650-47DE-ABA4-55F62388378F

Q40546181-28F154C8-18DA-44CA-82B8-70A3D60FB02C

Q40546181-2C25CA67-E9CF-4DB7-B663-953E727456DD

Q40546181-65DBA884-AD0C-4782-A773-057BE69F8911

Q40546181-7A73BCB4-AE42-43B5-9685-CD1B1EF789E8

Q40546181-A6835AF6-CE80-4538-A1BA-B03DAA62FD16

Q40546181-BFEF0C17-D5AC-4BC8-8DB3-5FC6C656A53B

Q40546181-E1DE1D5B-92C8-4712-B304-675606934504

P304

Q40546181-F618DB5E-A156-42DB-AEE1-2F07B0E810EE

P31

Q40546181-954FEEB8-11A4-45D4-87CF-10A2089863DB

P356

Q40546181-43006F7D-1FD8-42DF-9072-E8505C8F9D9F

P407

Q40546181-38AE7602-9B76-45D9-A068-0491F040CF72

P433

Q40546181-A27F503D-FDD4-4493-81E4-3B351C9847A1

P478

Q40546181-F1E3C264-B470-4846-A117-17481515AD87

P577

Q40546181-A4B1C044-3D23-4184-8B71-EDBB7CBDCE13

P5875

Q40546181-AFA0C844-B4E1-4FEF-BEAF-03B40FCE5655

P698

Q40546181-A5CDBC9D-DD05-4DDF-BF62-BB169F1EF078

P356

P1433

Clinical Infectious Diseases

P1476

Incidence of neutropenia durin ...... with piperacillin-tazobactam.

@en

P2093

F G Peralta

http://www.w3.org/2001/XMLSchema#string

M A Pena

http://www.w3.org/2001/XMLSchema#string

M A Tejero

http://www.w3.org/2001/XMLSchema#string

M B Sánchez

http://www.w3.org/2001/XMLSchema#string

M P Roíz

http://www.w3.org/2001/XMLSchema#string

R Arjona

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review.

Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis.

Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.

Antimicrobial therapy for diabetic foot infections. A practical approach.

Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease.

Antibiotic-induced agranulocytosis: a monocentric study of 21 cases.

A prospective study of neutropenia induced by high doses of beta-lactam antibiotics.

Adverse effects of monobactams and carbapenems.

Reversible bone marrow depression by high-dose piperacillin/tazobactam.

P304

1568-1572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/379519

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6833835

http://www.w3.org/2001/XMLSchema#string

P698

14614681

http://www.w3.org/2001/XMLSchema#string